open access

Vol 11, No 6 (2016)
Case Reports
Published online: 2017-01-17
Get Citation

Idiopathic ventricular fibrillation in a 30-year-old male*

Łukasz Rekść, Beata Wożakowska-Kapłon
DOI: 10.5603/FC.2016.0110
·
Folia Cardiologica 2016;11(6):557-561.

open access

Vol 11, No 6 (2016)
Case Reports
Published online: 2017-01-17

Abstract

Among ventricular arrhythmias ventricular fibrillation (VF) remains the most dangerous form leading to sudden cardiac arrest (SCA). Despite the use of advanced molecular biology techniques and recommendations suggesting autopsy studies of young people who died suddenly, still even half the SCD incidents in young people remains unclear. In the following report we present the diagnostic pathway and procedure based on appropriate guidelines, taking into consideration the realities of the Polish healthcare system.

Abstract

Among ventricular arrhythmias ventricular fibrillation (VF) remains the most dangerous form leading to sudden cardiac arrest (SCA). Despite the use of advanced molecular biology techniques and recommendations suggesting autopsy studies of young people who died suddenly, still even half the SCD incidents in young people remains unclear. In the following report we present the diagnostic pathway and procedure based on appropriate guidelines, taking into consideration the realities of the Polish healthcare system.

Get Citation

Keywords

idiopathic ventricular fibrillation, ventricular arhythmia, sudden cardiac death, secondary prevention

About this article
Title

Idiopathic ventricular fibrillation in a 30-year-old male*

Journal

Folia Cardiologica

Issue

Vol 11, No 6 (2016)

Pages

557-561

Published online

2017-01-17

DOI

10.5603/FC.2016.0110

Bibliographic record

Folia Cardiologica 2016;11(6):557-561.

Keywords

idiopathic ventricular fibrillation
ventricular arhythmia
sudden cardiac death
secondary prevention

Authors

Łukasz Rekść
Beata Wożakowska-Kapłon

References (32)
  1. Eckart RE, Shry EA, Burke AP, et al. Department of Defense Cardiovascular Death Registry Group. Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance. J Am Coll Cardiol. 2011; 58(12): 1254–1261.
  2. Drory Y, Turetz Y, Hiss Y, et al. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol. 1991; 68(13): 1388–1392.
  3. Puranik R, Chow CK, Duflou JA, et al. Sudden death in the young. Heart Rhythm. 2005; 2(12): 1277–1282.
  4. Maron BJ. Sudden death in young athletes. N Engl J Med. 2003; 349(11): 1064–1075.
  5. Lichtenfeld J, Deal BJ, Crawford S. Sudden cardiac arrest following ventricular fibrillation attributed to anabolic steroid use in an adolescent. Cardiol Young. 2016; 26(5): 996–998.
  6. van der Werf C, Hendrix A, Birnie E, et al. Improving usual care after sudden death in the young with focus on inherited cardiac diseases (the CAREFUL study): a community-based intervention study. Europace. 2016; 18(4): 592–601.
  7. Mazzanti A, O'Rourke S, Ng K, et al. The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases. Expert Rev Cardiovasc Ther. 2014; 12(4): 499–519.
  8. Wever EFD, Robles de Medina EO. Sudden death in patients without structural heart disease. J Am Coll Cardiol. 2004; 43(7): 1137–1144.
  9. Pedrote A, Errazquin F. Estado actual de la prevención y tratamiento de la muerte súbita. Rev Esp Cardiol. 1995; 48: 710–721.
  10. Dock W. Transitory ventricular fibrillation as a cause of syncope and its prevention by quinidine sulphate. American Heart Journal. 1929; 4(6): 709–714.
  11. Viskin S, Belhassen B. Idiopathic ventricular fibrillation. In: Gussak I, Antzelevitch C, Wilde AAM. ed. Electrical diseases of the heart: genetics, mechanisms, treatment, prevention. Springer-Verlag, London 2008: 508–606.
  12. Viskin S, Wilde AAM, Guevara-Valdivia ME, et al. Idiopathic ventricular fibrillation. Am Heart J. 1990; 120(3): 661–671.
  13. Viskin S, Lesh MD, Eldar M, et al. Mode of onset of malignant ventricular arrhythmias in idiopathic ventricular fibrillation. J Cardiovasc Electrophysiol. 1997; 8(10): 1115–1120.
  14. Haïssaguerre M, Shoda M, Jaïs P, et al. Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation. Lancet. 2002; 359(9307): 677–678.
  15. Mahida S, Derval N, Sacher F, et al. Sudden cardiac arrest associated with early repolarization. N Engl J Med. 2008; 358(19): 2016–2023.
  16. Haïssaguerre M, Sacher F, Nogami A, et al. Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. J Am Coll Cardiol. 2009; 53(7): 612–619.
  17. Lane RD, Laukes C, Marcus FI, et al. Psychological stress preceding idiopathic ventricular fibrillation. Psychosom Med. 2005; 67(3): 359–365.
  18. Reich P, DeSilva RA, Lown B, et al. Acute psychological disturbances preceding life-threatening ventricular arrhythmias. JAMA. 1981; 246(3): 233–235.
  19. Reznick JW, Braunstein DB, Walsh RL, et al. Lyme carditis. Electrophysiologic and histopathologic study. Am J Med. 1986; 81(5): 923–927.
  20. McAlister HF, Klementowicz PT, Andrews C, et al. Lyme carditis: an important cause of reversible heart block. Ann Intern Med. 1989; 110(5): 339–345.
  21. Nagi KS, Joshi R, Thakur RK. Cardiac manifestations of Lyme disease: a review. Can J Cardiol. 1996; 12(5): 503–506.
  22. Vlay SC, Dervan JP, Elias J, et al. Ventricular tachycardia associated with Lyme carditis. Am Heart J. 1991; 121(5): 1558–1560.
  23. Greenberg YJ, Brennan JJ, Rosenfeld LE. Lyme myocarditis presenting as fascicular tachycardia with underlying complete heart block. J Cardiovasc Electrophysiol. 1997; 8(3): 323–324.
  24. Maroszyńska-Dmoch E, Wozakowska-Kapłon B. [May Lyme borreliosis lead to heart transplantation? - a case report]. Kardiol Pol. 2009; 67(5): 516–520.
  25. Bugiardini R, Manfrini O, De Ferrari GM. Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. Arch Intern Med. 2006; 166(13): 1391–1395.
  26. Roe MT, Harrington RA, Prosper DM, et al. Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. Circulation. 2000; 102(10): 1101–1106.
  27. Conte G, Caputo ML, Regoli F, et al. True idiopathic ventricular fibrillation in out-of-hospital cardiac arrest survivors in the Swiss Canton Ticino: prevalence, clinical features, and long-term follow-up. Europace. 2016 [Epub ahead of print]; 19(2): 259–266.
  28. Haïssaguerre M, Shah DC, Jaïs P, et al. Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation. Lancet. 2002; 359(9307): 677–678.
  29. Nogami A, Sugiyasu A, Kubota S, et al. Mapping and ablation of idiopathic ventricular fibrillation from the Purkinje system. Heart Rhythm. 2005; 2(6): 646–649.
  30. Noda T, Shimizu W, Taguchi A, et al. Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract. J Am Coll Cardiol. 2005; 46(7): 1288–1294.
  31. Nogami A. Mapping and ablating ventricular premature contractions that trigger ventricular fibrillation: trigger elimination and substrate modification. J Cardiovasc Electrophysiol. 2015; 26(1): 110–115.
  32. Ciemny S, Kwiatkowska J, Królak T, et al. Nastolatek traci przytomność na ulicy. Folia Cardiologica. 2016; 11(1): 61–65.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl